🇫🇷
France · FR · FR:67503464
TRANSLARNA 125 mg, granulés pour suspension buvable
ATC M09AX03
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerPTC THERAPEUTICS INTERNATIONAL (IRLANDE)
CountryFR (France)
ATC codeM09AX03
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip13340092795914130 sachet(s) aluminium
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "67503464",
"date_amm": "2014-07-31",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/902",
"statut_amm": "Autorisation archivée",
"statut_bdm": "Alerte",
"forme_pharmaceutique": "granulés pour suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code M09AX03.
- FITranslarnaPTC Therapeutics International Limited
- IETranslarnaPTC Therapeutics International Limited
- IETranslarnaPTC Therapeutics International Limited
- PLTranslarnaPTC Therapeutics International Limited
- PLTranslarnaPTC Therapeutics International Limited
- PLTranslarnaPTC Therapeutics International Limited
- IETranslarnaPTC Therapeutics International Limited
- FITranslarnaPTC Therapeutics International Limited
Access this data programmatically
Query TRANSLARNA 125 mg, granulés pour suspension buvable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.